Canadian Cancer Society logo

Multiple myeloma

You are here: 

Consolidation therapy for multiple myeloma

Consolidation therapy for multiple myeloma is given after a stem cell transplant. It’s a short course of chemotherapy that helps make the previous chemotherapy treatment and stem cell transplant work better. Consolidation therapy also helps to keep the multiple myeloma in remission for longer.

Consolidation therapy for people with multiple myeloma who have had a stem cell transplant is most often the VRD regimen. The VRD regimen uses bortezomib (Velcade), lenalidomide (Revlimid) and dexamethasone (Decadron, Dexasone).

Stories

Now I know that I will help someone with cancer even after I’m gone. It’s a footprint I want to leave behind me.

Read Barbara's story

Volunteers provide comfort and kindness

Illustration of volunteers

Thousands of Canadian Cancer Society volunteers work in regional cancer centres, lodges and community hospitals to support people receiving treatment.

Learn more